Viral receptors and vector purification: New approaches for generating clinical-grade reagents

被引：47
|
作者：
Summerford, C
Samulski, RJ
机构：
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
来源：
NATURE MEDICINE | 1999年 / 5卷 / 05期
关键词：
D O I：
10.1038/8470
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：587 / 588
页数：2
相关论文
共 50 条
  • [31] Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in Cell Factories
    M Przybylowski
    A Hakakha
    J Stefanski
    J Hodges
    M Sadelain
    I Rivière
    Gene Therapy, 2006, 13 : 95 - 100
  • [32] Dual Tangential Flow Purification Improves Downstream Processing of Large Scale Clinical-Grade Preparations of Lentiviral Vectors for Phase I/II Clinical Trials
    Wohlfahrt, Martin E.
    Woodle, Douglas
    Manger, Ronald
    Adams, Amie
    Olsen, Philip
    Beard, Brian C.
    Sahai, Suchit
    Till, Brian G.
    Kiem, Hans-Peter
    MOLECULAR THERAPY, 2018, 26 (05) : 152 - 153
  • [33] Isolation of the Stromal Vascular Fraction Using a New Protocol with All Clinical-Grade Drugs: From Basic Study to Clinical Application
    Qin, Jiaqi
    Cheng, Chen
    Huang, Ru-Lin
    He, Jizhou
    Zhou, Shuangbai
    Tan, Poh-Ching
    Zhang, Tianyu
    Fang, Bin
    Li, Qingfeng
    Xie, Yun
    AESTHETIC PLASTIC SURGERY, 2024, 48 (22) : 4702 - 4711
  • [34] Purification of clinical-grade disulfide stabilized antibody fragment variable—Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli
    Hua Jiang
    Yueqing Xie
    Andrew Burnette
    John Roach
    Steven L. Giardina
    Toby T. Hecht
    Stephen P. Creekmore
    Gautam Mitra
    Jianwei Zhu
    Applied Microbiology and Biotechnology, 2013, 97 : 621 - 632
  • [35] Production of replication-defective HSV-1 viral vectors and development of precise assay systems to analyze the quality of clinical-grade HSV vectors
    Ozuer, A
    Wechuck, JB
    Wendell, SK
    Wolfe, DP
    Goins, WF
    Krisky, DM
    Ataai, MM
    Glorioso, JC
    MOLECULAR THERAPY, 2003, 7 (05) : S365 - S366
  • [36] Purification of clinical-grade disulfide stabilized antibody fragment variable-Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli
    Jiang, Hua
    Xie, Yueqing
    Burnette, Andrew
    Roach, John
    Giardina, Steven L.
    Hecht, Toby T.
    Creekmore, Stephen P.
    Mitra, Gautam
    Zhu, Jianwei
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2013, 97 (02) : 621 - 632
  • [37] Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency
    van der Loo, J. C. M.
    Swaney, W. P.
    Grassman, E.
    Terwilliger, A.
    Higashimoto, T.
    Schambach, A.
    Hacein-Bey-Abina, S.
    Nordling, D. L.
    Cavazzana-Calvo, M.
    Thrasher, A. J.
    Williams, D. A.
    Reeves, L.
    Malik, P.
    GENE THERAPY, 2012, 19 (08) : 872 - 876
  • [38] Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency
    J C M van der Loo
    W P Swaney
    E Grassman
    A Terwilliger
    T Higashimoto
    A Schambach
    S Hacein-Bey-Abina
    D L Nordling
    M Cavazzana-Calvo
    A J Thrasher
    D A Williams
    L Reeves
    P Malik
    Gene Therapy, 2012, 19 : 872 - 876
  • [39] A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19
    Singh, Harjeet
    Huls, Helen
    Kebriaei, Partow
    Cooper, Laurence J. N.
    IMMUNOLOGICAL REVIEWS, 2014, 257 (01) : 181 - 190
  • [40] On the Separation of Yttrium-90 from High-Level Liquid Waste: Purification to Clinical-Grade Radiochemical Precursor, Clinical Translation in Formulation of 90Y-DOTATATE Patient Dose
    Mitra, Arpit
    Chakraborty, Avik
    Gaikwad, Sujay
    Tawate, Megha
    Upadhye, Trupti
    Lad, Sangita
    Sahoo, Sudip
    Jagesia, Poonam
    Parghane, Rahul
    Menon, Sreeja
    Basu, Sandip
    Dhami, Prem Singh
    Banerjee, Sharmila
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2021, 36 (02) : 143 - 159
12345